Covered recipient · General Payments record
SARAH ANN WYMAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2022–2024
$10,160.02
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,342.50 | 3 |
| Food and Beverage | $643.10 | 6 |
| Education | $74.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $1,522.50 | 2 |
| Janssen Global Services, LLC | $820.00 | 1 |
| ABBVIE INC. | $244.92 | 2 |
| Janssen Scientific Affairs, LLC | $212.87 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $108.48 | 1 |
| Legend Biotech USA Inc. | $76.83 | 1 |
| Incyte Corporation | $74.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $122.46 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108259410 | CMS |
| ABBVIE INC. | $122.46 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108259412 | CMS |
| Incyte Corporation | $74.99 | 09/14/2024 | Education | Undisputed | 01/23/2026 | 1141191077 | CMS |
| Janssen Biotech, Inc. | $1,160.00 | 05/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1078524168 | CMS |
| Janssen Biotech, Inc. | $362.50 | 05/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1078526437 | CMS |
| Janssen Global Services, LLC | $820.00 | 09/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077590839 | CMS |
| Janssen Scientific Affairs, LLC | $82.05 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078848701 | CMS |
| Janssen Scientific Affairs, LLC | $130.82 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078848693 | CMS |
| Legend Biotech USA Inc. | $76.83 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131692177 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $108.48 | 05/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144984490 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.